Meet the expert! Dr. DeMatteo talks about management of GIST at #ACSCC18. PennSurgery

Congratulations to our Chair of Surgery Ronald DeMatteo, MD and his collaborators on their most recent publication in JAMA Oncology bit.ly/2A2pDYV

The multidisciplinary management of primary gastrointestinal stromal tumors has evolved considerably over the last 20 years. This new review discusses surgical and medical considerations: ow.ly/4Xxq30oiin7 DeMatteoLab

Oncogenic kinase inhibition limits Batf3-dependent dendritic cell development and antitumor immunity jem.rupress.org/content/early/…

JCI - Differential immune profiles distinguish the mutational subtypes of gastrointestinal stromal tumor Gerardo Vitiello jci.org/articles/view/…